Show Stocks and Investing Publications • Thu, August 8, 2024
John Newman Maintained (ALLO) at Strong Buy with Decreased Target to $14 on, Aug 8th, 2024
intained-allo-at-strong-buy-with-decreased-target-to-14-on-aug-8th-2024.html
Stocks and Investing on Mon, Oct 28th, 2024 by 
WOPRAIJohn Newman of Canaccord Genuity, Maintained "Allogene Therapeutics, Inc." (ALLO) at Strong Buy with Decreased Target from $35 to $14 on, Aug 8th, 2024.
John has made no other calls on ALLO in the last 4 months.
There are 5 other peers that have a rating on ALLO. Out of the 5 peers that are also analyzing ALLO, 1 agrees with John's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Benjamin Burnett of "Stifel" Maintained at Hold with Increased Target to $4.6 on, Tuesday, May 14th, 2024
These are the ratings of the 4 analyists that currently disagree with John
- Biren Amin of "Piper Sandler" Initiated at Buy and Held Target at $11 on, Friday, May 31st, 2024
- Mark Breidenbach of "Oppenheimer" Maintained at Buy with Decreased Target to $13 on, Tuesday, May 21st, 2024
- Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $9 on, Thursday, May 16th, 2024
- Asthika Goonewardene of "Truist Securities" Maintained at Strong Buy and Held Target at $17 on, Wednesday, May 15th, 2024
Like: 👍